Litcius/Paper detail

Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer

Boris Sepesi, Nicolas Zhou, William N. William, Heather Lin, Cheuk Hong Leung, Annikka Weissferdt, K. G. Mitchell, Apar Pataer, Garrett L. Walsh, David C. Rice, Jack A. Roth, Reza J. Mehran, Wayne L. Hofstetter, Mara B. Antonoff, Ravi Rajaram, Marcelo V. Negrão, Anne S. Tsao, Don L. Gibbons, J. Jack Lee, John V. Heymach, Ara A. Vaporciyan, Stephen G. Swisher, Tina Cascone

2022Journal of Thoracic and Cardiovascular Surgery94 citationsDOIOpen Access PDF

Topics & Concepts

NivolumabMedicineIpilimumabPerioperativeLung cancerNeoadjuvant therapySurgeryChemotherapyCancerInternal medicineOncologyBreast cancerImmunotherapyCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical Imaging
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer | Litcius